Clinical Trials Directory

Trials / Completed

CompletedNCT03036514

Sublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia After Back Surgery.

Sublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia (PCIA) With Morphine for Postoperative Pain After Back Surgery. A Single Center Case-control Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
University Hospital, Antwerp · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

In this study, numeric rating scale (NRS) and side effects are measured after usage of a sublingual sufentanil tablet system (SSTS) in comparison to intravenous patient controlled analgesia (PCIA).

Detailed description

Sublingual sufentanil tablet system (SSTS) is compared in pain relief and side effect profile with the routinely used intravenous patient controlled analgesia (PCIA) with morphine in the postoperative phase after back surgery. The common use of PCIA with morphine is associated with a rather slow onset-time and active metabolites, with occurrence of potential harmful side effects as sedation and desaturation. This mono-centric project involving American Society of Anesthesiologists (ASA) classification I-II patients undergoing elective neurosurgery (laminectomy) are recruited. Enrolled patients undergo numeric rating scale (NRS) and side effect questionnaire during the first 72h postoperatively.

Conditions

Interventions

TypeNameDescription
DEVICESublingual sufentanil tablet systemUsage of a new patient-controlled SSTS in the postoperative phase after laminectomy or spinal fusion.
DRUGPatient-controlled intravenous analgesiaUsage of classically used patient-controlled intravenous mophine-based postoperative analgesia after laminectomy or spinal fusion.

Timeline

Start date
2017-04-05
Primary completion
2019-08-01
Completion
2019-09-01
First posted
2017-01-30
Last updated
2020-03-09

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03036514. Inclusion in this directory is not an endorsement.